SEP 16, 2021 12:00 PM PDT

Scientists Create Tiny Replicas Of The Pancreas To Study New Drugs

WRITTEN BY: Ryan Vingum

Pancreatic cancer it’s often hard to diagnose in its early stages, resulting in patients having more advanced cancer at diagnosis that is much harder to treat. 

Studying ways to treat pancreatic cancer is also challenging (as with any cancer). Researchers often try to replicate the environment that tumors live ex vivo, sometimes with real patient cells, to better understand how a tumor might respond to different types of treatment. Organic gels are commonly used to accomplish this, gels that contain a range of proteins intended to replicate the environment tumors grow in and allow researchers to grow organ tissues. However, most gels that are produced don’t do an adequate job replicating the extracellular environment around tumors and are difficult to produce consistently, making it difficult to get replicable results.

Researchers at Massachusetts Institute of Technology (MIT) have developed a new polyethylene glycol-based gel that may address the efficacy concerns of existing gels, while being easy to produce consistently.

"The issue of reproducibility is a major one," says Linda Griffith, a professor of biological and mechanical engineering. "The research community has been looking for ways to do more methodical cultures of these kinds of organoids, and especially to control the microenvironment."

Researchers published a description of their gel model in Nature. When trying to determine the best way to replicate the extracellular environment, researchers noted that a key feature that needed to be present in their gel were peptide ligands, which interact with integrins on cells and allow them adhere to each other and form tissue, allowing researchers to develop miniature pancreatic organs.

When testing their gel, researchers were not only able to grow miniature versions of pancreatic tumors using pancreatic cancer patient cells, but the environment surrounding the tumor was much more similar to what it would look like in a patient’s body. For example, macrophages and fibroblasts were able to grow in the gel, replicating an actual tumor’s extracellular environment. With the ability to develop more specific and accurate conditions ex vivo, researchers may be able to better understand how different drugs interact with tumors.  

The research team noted their gel could be utilized to grow other types of tissue, aiding in the study of other cancers. 

Sources: Science Daily; Mayo Clinic; Nature

About the Author
Professional Writing
Science writer and editor, with a focus on simplifying complex information about health, medicine, technology, and clinical drug development for a general audience.
You May Also Like
OCT 11, 2022
Clinical & Molecular DX
Researchers Discover Method of Synthesizing a Cancer Drug Discovered in the Australian Rainforest
OCT 11, 2022
Researchers Discover Method of Synthesizing a Cancer Drug Discovered in the Australian Rainforest
Tigilanol tiglate (also referred to as EBC-46) is a chemical compound with a storied history. Found naturally in the see ...
NOV 11, 2022
Chemistry & Physics
Grad Student Highlights: Andrew Saydjari (Harvard University)
NOV 11, 2022
Grad Student Highlights: Andrew Saydjari (Harvard University)
This interview series is focused on the graduate student experience across all STEM fields that allows them to get their ...
NOV 08, 2022
Technology
People say too much screen time is bad for kids. But is it really the problem?
NOV 08, 2022
People say too much screen time is bad for kids. But is it really the problem?
Screen time is a parent’s conundrum. How much screen time is too much? How do I adequately monitor my child’ ...
NOV 16, 2022
Earth & The Environment
New Details About Earth's First Mass Extinction Unveiled by Geobiologists
NOV 16, 2022
New Details About Earth's First Mass Extinction Unveiled by Geobiologists
In a recent study published in the Proceedings of the National Academy of Sciences, a team of researchers led by Virgini ...
NOV 14, 2022
Cancer
Breast Cancer Vaccine Shows Promise as it Enters Phase 2 Trial
NOV 14, 2022
Breast Cancer Vaccine Shows Promise as it Enters Phase 2 Trial
About 20% of breast cancers exhibit elevated levels of a protein known as HER2.  You may have heard the classifier ...
NOV 23, 2022
Drug Discovery & Development
Nanoneedles for Ocular Drug Delivery
NOV 23, 2022
Nanoneedles for Ocular Drug Delivery
The eye is a readily available part of the human body, yet drug delivery there is incredibly difficult. Most ocular drug ...
Loading Comments...